A rapid evolutionary process provides Sudanese Copts with resistance to malaria
Peer-Reviewed Publication
Updates every hour. Last Updated: 1-Jun-2026 13:16 ET (1-Jun-2026 17:16 GMT/UTC)
An international study investigating the genomic diversity of the Sudanese population reveals that the Copts originating in Egypt –who settled in the country between the seventh and eleventh centuries– have acquired a genetic variant that protects them from contracting malaria. “The acquisition of this variant has taken place very quickly, in just 1,500 years, after a group of Copts mixed with Sudanese populations with sub-Saharan characteristics”, explains David Comas, principal investigator at the Institute of Evolutionary Biology (IBE: CSIC-Pompeu Fabra University) and a full professor and researcher at the UPF Department of Medicine and Life Sciences, who has led the research. The study of 125 high-coverage genomes representing five of the country’s ethnolinguistic groups has enabled describing more than a million novel genetic variants, 1,500 of which could have implications for diseases.
As federal policymakers weigh potential changes to how biomedical research is funded and regulated in the United States, a Virginia Tech scientist highlights the importance of preserving the nation’s ability to turn discovery into life‑saving therapies.
Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the range of conditions that can be identified at birth. Next-generation sequencing is being explored as a complementary screening tool. A review published in Pediatric Investigation examines how next-generation sequencing could expand NBS from single-disease assays to genome-enabled, multi-disease screening approaches.